SAFC acquires Molecular Medicine Bioservices

09 May 2007 22:01  [Source: ICIS news]

BOSTON (ICIS news)--Sigma Aldrich Fine Chemicals (SAFC) has acquired Carlsbad, California-based Molecular Medicine Bioservices (MMB) in lieu of building its own clinical biologics manufacturing facility for its pharmaceuticals business unit, SAFC said on Wednesday at the BIO 2007 conference.

“SAFC had already designed and engineered a facility for construction in St. Louis, Missouri, but instead went with this acquisition. It saves us time and adds $12m [€8.9m] in annual revenues, which MMB brings in,” said Frank Wicks, president of SAFC.

MMB’s core expertise revolves around the development and clinical manufacturing of viral products.

SAFC said the acquisition fits with its continued search to fill in the missing gaps in specialised niche area technologies and capabilities.

“Not many companies have this expertise in niche areas, and big pharma is looking for companies that already have these technologies ready to go,” said Wicks.

SAFC was also continuing to search for more capacity in large-scale, flexible key pharmaceutical intermediates, and in additional US-based current good manufacturing practices (cGMP) manufacturing.

By: Feliza Mirasol
+1 713 525 2653

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly